CIK 0001281895 · Non-accelerated filer<br>Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $405,500
- in 5 filings
Net −$405,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-26 | Militello John See Remarks | Grant or award · Stock Option (Right to Buy) | +9,091 | 9,091 | ||
| 2026-05-21 | Shah Gaurav CEO | Option exercise | +76,490 | $1.69 | $129K | 1,117,408 |
| 2026-05-21 | Shah Gaurav CEO | Sale | −55,684 | $3.09 | $172K | 1,061,724 |
| 2026-05-21 | Shah Gaurav CEO | Option exercise · Stock Option (Right to Buy) | −76,490 | $1.69 | $129K | 0 |
| 2026-05-19 | Shah Gaurav CEO | Sale | −2,409 | $3.01 | $7K | 1,040,918 |
| 2026-05-19 | Wilson Martin General Counsel | Sale | −662 | $3.01 | $2K | 677,977 |
| 2026-05-19 | Militello John See Remarks | Sale | −384 | $3.01 | $1K | 89,780 |
| 2026-05-13 | Wilson Martin General Counsel | Sale | −3,361 | $3.61 | $12K | 678,639 |
| 2026-05-13 | Shah Gaurav CEO | Sale | −2,728 | $3.61 | $10K | 1,043,327 |
| 2026-05-13 | Militello John See Remarks | Sale | −855 | $3.61 | $3K | 90,164 |
| 2026-05-07 | Chaudhuri Sarbani See Remarks | Sale | −17,650 | $3.84 | $68K | 267,510 |
| 2026-02-18 | Militello John See Remarks | Sale | −1,157 | $3.34 | $4K | 91,019 |
| 2026-02-18 | Shah Gaurav CEO | Sale | −5,990 | $3.34 | $20K | 1,046,055 |
| 2026-02-18 | Wilson Martin General Counsel | Sale | −1,376 | $3.34 | $5K | 682,000 |
| 2026-02-13 | Wilson Martin General Counsel | Sale | −12,253 | $3.31 | $41K | 683,376 |
| 2026-02-13 | Militello John See Remarks | Sale | −3,726 | $3.31 | $12K | 92,176 |
| 2026-02-13 | Shah Gaurav CEO | Sale | −12,279 | $3.31 | $41K | 1,052,045 |
| 2026-02-11 | Shah Gaurav CEO | Grant or award | +286,028 | 1,064,324 | ||
| 2026-02-11 | Shah Gaurav CEO | Grant or award · Stock Option (Right to Buy) | +870,648 | 870,648 | ||
| 2026-02-11 | Militello John See Remarks | Grant or award | +29,982 | 95,902 |
Page 3 of 9 · 164 trades